SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma subsidiary gets USFDA nod for anti-hypertension drug

19 Nov 2009 Evaluate

Drug firm Sun Pharmaceutical Industries subsidiary has received US Drug regulator USFDA approval for anti-hypertension drug yesterday. The anti hyper tension drug is Nicardipine Hydrochloride injections, that will be available in the strength of 25 mg/10ml. The injections are used for short-term treatment of hypertension when oral therapy is not feasible.

crackcrack

Sun Pharma Inds. Share Price

1670.00 2.00 (0.12%)
21-Apr-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.00
Dr. Reddys Lab 1222.45
Cipla 1230.60
Zydus Lifesciences 931.55
Lupin 2323.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×